| Compare the Efficacy and Safety of KH607 Tablets Versus Vortioxetine Hydrobromide Tablets in Adult Patients With Major Depressive Disorder (NCT07741331) | Chengdu Kanghong Pharmaceutical Group Co., Ltd. | 2026-07-01 |
| A Study of KH607 as Monotherpy in Adults Participants With Major Depressive Disorder (NCT07741240) | Chengdu Kanghong Pharmaceutical Group Co., Ltd. | 2026-07-01 |
| A Study to Evaluate the Effect of Food on the Pharmacokinetic Characteristics and Safety Profile of KH607 in Healthy Chinese Participants (NCT07634874) | Chengdu Kanghong Pharmaceutical Group Co., Ltd. | 2026-06-01 |
| A Phase 1 Study of KHN707 Tablets in Healthy Participants (NCT07557537) | Chengdu Kanghong Pharmaceutical Group Co., Ltd. | 2026-05-01 |
| Efficacy and Safety of KHN702 Tablets in Moderate to Severe Post-operative Pain Subjects (NCT07277933) | Chengdu Kanghong Pharmaceutical Group Co., Ltd. | 2025-12-01 |
| A Phase 2 Study to Evaluate Efficacy and Safety of KH607 Tablets in Woman With Postpartum Depression (NCT07096791) | Chengdu Kanghong Pharmaceutical Group Co., Ltd. | 2025-09-02 |
| A Phase 1 Study of KHN702 Tablets in Healthy Subjects (NCT07044960) | Chengdu Kanghong Pharmaceutical Group Co., Ltd. | 2025-06-21 |
| A Phase 2 Study to Evaluate Efficacy and Safety of KH607 Tablets in Adult Participents With Major Depressive Disorder (NCT07101120) | Chengdu Kanghong Pharmaceutical Group Co., Ltd. | 2025-03-19 |
| A Double-Blind, Randomized Comparative Study of Carliprazine and Aripiprazole in Patients with Acute Schizophrenia (NCT06589817) | Chengdu Kanghong Pharmaceutical Group Co., Ltd. | 2024-10-01 |
| Phase 1 Study of KH607 Tablets (NCT06393803) | Chengdu Kanghong Pharmaceutical Group Co., Ltd. | 2023-10-21 |
| Bioequivalence Study of Bosiqing and ABILIFY Under Fasting/Fed Condition (NCT03232710) | Chengdu Kanghong Pharmaceutical Group Co., Ltd. | 2017-06-26 |